Philips has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Verida system.
The device is an AI-powered detector-based spectral computed tomography (CT) system developed to improve diagnostic accuracy across clinical applications.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Verida integrates Spectral Precise Image technology using a third-generation Nano-panel Precise dual-layer detector that offers intrinsic noise reduction and an AI-based deep learning reconstruction engine.
These features are intended to reduce noise and improve image quality throughout CT imaging. Clinicians have the flexibility to customise image de-noising according to their preferences.
Verida allows uninterrupted spectral imaging based on Philips’ detector-based spectral CT technology, eliminating the need for separate scans or workflow changes.
The system has enhanced features to support clinical workflows, including improvements to the spectral result generation pipeline and updated computing infrastructure for improved performance and usability.
It reconstructs 145 images per second, enabling entire exams to be available in under 30 seconds and supporting up to 270 exams daily.
By capturing both high-energy and low-energy data in a single scan, clinicians receive both conventional and spectral results for advanced tissue characterisation and material differentiation, reducing the need for pre-selection or repeat scans.
Verida is suitable for diagnostic imaging in interventional radiology, radiology, cardiology, and oncology.
It is indicated for head, whole body, cardiac, and vascular applications in patients of all ages, and may also be used for low-dose CT lung cancer screening, as well as treatment preparation and radiation therapy planning.
Philips CT business leader Dan Xu said: “With FDA clearance for Verida, we are bringing the next evolution of spectral CT to more markets. By combining always-on spectral imaging with AI-powered reconstruction, Verida enables clinicians to see more, first time right, supporting faster, more informed decisions and expanding the role of CT across clinical pathways.”
Last month, Philips obtained FDA clearance for DeviceGuide, an AI-based software designed to provide physicians with real-time visual assistance during mitral valve repair procedures.
